Health
For Seniors with IBD, Think Safety with Treatments – MedPage Today
Hospitalizations risks were lower with vedolizumab than TNF inhibitors
Among older adults with inflammatory bowel disease (IBD), vedolizumab (Entyvio) appeared to be safer than tumor necrosis factor (TNF) inhibitors, a large retrospective study suggested.
After weighting using standardized mean differences, new users of vedolizumab had a lower likelihood of all-cause hospitalization during the 12 months after initiating biologic treatment compared with those starting TNF inhibitors, with a hazard ratio of 0.81 (95% CI 0.68-0.96), according to Bharati Kochar, MD, of…
-
Noosa News18 hours agoWoman was watching keepers work when lion attacked, Darling Downs Zoo says
-
Noosa News17 hours agoWorking for someone else made it hard to care for my daughter. So I quit
-
General21 hours agoDeveloper warns wind energy capacity may not be ready by WA coal deadline
-
General14 hours agoQantas ‘contacted by potential cybercriminal’ after attack on data of up to 6 million customers